Compare NRC & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRC | CGNT |
|---|---|---|
| Founded | 1981 | 2020 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.8M | 704.1M |
| IPO Year | N/A | N/A |
| Metric | NRC | CGNT |
|---|---|---|
| Price | $18.80 | $9.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 89.9K | ★ 289.8K |
| Earning Date | 01-26-2026 | 12-09-2025 |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | $139,102,000.00 | ★ $388,304,000.00 |
| Revenue This Year | N/A | $16.36 |
| Revenue Next Year | N/A | $10.86 |
| P/E Ratio | $26.28 | ★ N/A |
| Revenue Growth | N/A | ★ 14.27 |
| 52 Week Low | $9.76 | $7.64 |
| 52 Week High | $19.39 | $11.66 |
| Indicator | NRC | CGNT |
|---|---|---|
| Relative Strength Index (RSI) | 65.79 | 56.06 |
| Support Level | $18.50 | $9.41 |
| Resistance Level | $19.20 | $9.86 |
| Average True Range (ATR) | 0.73 | 0.34 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 83.81 | 53.38 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.